Intermediate dose interferon alfa 2 B (IFN alfa 2B) in adjuvant tratment for malignant melanoma

被引：0
|
作者：
Savio, Giuseppina [1 ]
Calabria, Caterina [1 ]
Laudani, Agata [1 ]
Pepe, Alessio [1 ]
Palmisano, Valentina [1 ]
Leonardi, Vita [1 ]
Usset, Antonella [1 ]
Arcuri, Carmen [1 ]
Giresi, Armando [1 ]
Agostara, Biagio [1 ]
机构：
[1] ARNAS Civico, Palermo, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：168 / 168
页数：1
相关论文
共 50 条
  • [1] INTERMEDIATE DOSE INTERFERON ALFA 2B (IFN ALFA 2B) IN ADJUVANT TREATMENT OF MALIGNANT MELANOMA
    Calabria, Caterina
    Savio, Giuseppina
    Laudani, Agata
    Leonardi, Vita
    Blasi, Livio
    Stefano, Rosalba
    Agostara, Biagio
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 88 - 89
  • [2] Intermediate dose interferon alfa 2b (IFN alfa 2b) in adiuvant treatment for malignant melanoma
    Agostara, B.
    Savio, G.
    Calabria, C.
    Leonardi, V.
    Laudani, Agata
    Pepe, A.
    Rondello, G.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 59 - 60
  • [3] Low and intermediate dose interferon alfa2b as adjuvant therapy of cutaneous malignant melanoma
    Paz-Carreira, JM
    Calvo, L
    Alonso, G
    Valladares, M
    Gonzalez, MA
    Aparicio, LA
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 118 - 118
  • [4] Intermediate dose interferon alpha 2b (IFN alpha 2b) in adiuvant treatment for Malignant Melanoma
    Savio, G.
    Calabria, C.
    Leonardi, V.
    Laudani, A.
    Pepe, A.
    Blasi, L.
    Usset, A.
    Rondello, G.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 171 - 171
  • [5] Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma
    Lohmann, CP
    Kroher, G
    Bogenrieder, T
    Spiegel, D
    Preuner, J
    [J]. LANCET, 1999, 353 (9161): : 1326 - 1326
  • [6] Interferon alfa-2b or not 2b? Significant differences exist in the decision-making process between melanoma patients who accept or decline high-dose adjuvant interferon alfa-2b treatment
    Bramlette, Tracy B.
    Lawson, David H.
    Washington, Carl V.
    Veledar, Emir
    Johns, Barry R.
    Brisman, Stacey F.
    Abramova, Liana
    Chen, Suephy C.
    [J]. DERMATOLOGIC SURGERY, 2007, 33 (01) : 11 - 16
  • [7] Adjuvant interferon alfa-2b for high-risk melanoma
    Retsas, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) : 1968 - 1968
  • [8] Results of the Nordic randomised adjuvant trial of intermediate-dose interferon alfa-2b in high-risk melanoma
    Hansson, J.
    Aamdal, S.
    Bastholt, L.
    Hernberg, M.
    Nilsson, B.
    Stierner, U.
    von der Maase, H.
    [J]. EJC SUPPLEMENTS, 2007, 5 (06): : 4 - 4
  • [9] Economic analysis of adjuvant Interferon-ALFA 2B (IFN) in high risk melanoma using projections from ECOG (E) 1684
    Hillner, BE
    Kirkwood, JM
    Atkins, MB
    Johnson, ER
    Smith, TJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : PP34 - PP34
  • [10] High-dose interferon α2b in malignant melanoma
    不详
    [J]. ONKOLOGIE, 1999, 22 (04): : 334 - 335
12345